Bill Wexler's Profits of DOOM Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bill Wexler's Profits of DOOM

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jim Roof who wrote (158)	2/26/1998 5:52:00 PM
From: Bill Wexler	Read Replies (1) of 4634

<<I have called you to task on BTIM with the DATA that was released from the Phase III trials>> The data from the phase III trials showed no statistically significant difference between Hextend and Hespan. Hextend was dinged only in serious AEs (one more than Hespan). Did I miss anything? <<I have caught you trying to convince some readers here that TRBO's ovens require a complex order of steps to simply cook a burger (read your own post, Bill)>> I did. Now read my follow-up posts. Once again, you are overblowing a trivial point. This is equivalent to people who flame others for minor spelling errors, etc. The fact of the matter is my analysis of the company's financials and the viability of their product is dead on the money. I was simply trying to point out that the Turbochef oven is very complex and overpriced (i.e. it has a computer interface and lots of geegaws) and wouldn't readily be accepted by fast food franchises. <<You are making quite an assumption here Bill. I have not lost money.>> I would bet that you are at a net loss from all your trading in the stock market. I've read some of your past posts. Hate to tell you this Jim but I get the impression that you'd be better off putting your cash into CDs or an index fund. <<I feel that the facts are on the side of the longs>> I live near Berkeley. I've seen the company. I've talked to many people who've been or are currently associated with some of the principals. I promise you that you couldn't be more wrong. <<I trust Abbott Labs involvement with BTIM a heck of a lot more than the opinion of someone who has routinely shown such disregard for physical data>> This is a common error novice investors such as yourself make when speculating on Biotech companies. Large pharms make these sorts of deals with dozens upon dozens of development stage companies all the time. The vast majority of these licensing arrangements never amount to anything. The hope is that one good drug or technology will make up for many losers. <<and circumstantial evidence (no insider selling and BTIM shares being used as leverage to buy MORE BTIM shares by the principals).>> Now you are babbling nonsense. I already pointed out that key insiders have used their Biotime shares as collateral to open margin accounts at Montgomery securities. This is a common (yet somewhat unethical) way officers that are under trading restrictions can effectively liquidate their holdings without raising 144 flags. The same technique was used by Solv-ex management before the company collapsed. One director bought a miniscule number of shares some time back to generate a positive-looking 144. This is also a common ruse. Compare the number of shares bought to the massive number of shares put up as collateral in the SC13 filings. <<So long Bill.>> Is that a promise? Biotime down another $1 today in a strong tech rally.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next